Incyte Quarterly Balance Sheet
NASDAQ: INCYHealth CareBiotechnology: Commercial Physical & Biological ResarchUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Incyte financial position
As of Mar 31, 2026, Incyte reported total assets of $7.34 billion, up 27.7% from a year earlier against total liabilities of $1.72 billion. Shareholders' equity stood at $5.62 billion, or 76.6% of assets. The company held $3.46 billion in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 3.68, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
Incyte balance sheet (quarterly)
| Quarter (USD) | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 | Q2 20232023-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 3.46B | 3.10B | 2.46B | 1.95B | 1.94B | 1.69B | 1.30B | 987.29M | 3.35B | 3.21B | 3.23B | 3.13B |
| Short-Term Investments | — | — | — | — | — | — | 467.24M | 462.21M | 504.48M | 442.67M | 289.22M | 292.24M |
| Inventory | 115.62M | 101.06M | 83.45M | 83.42M | 63.98M | 58.87M | 70.44M | 100.70M | 63.64M | 62.97M | 57.20M | 35.94M |
| Total Current Assets | 5.48B | 5.02B | 4.28B | 3.64B | 3.51B | 3.24B | 2.81B | 2.57B | 4.85B | 4.65B | 4.40B | 4.26B |
| Property, Plant & Equipment | 720.17M | 730.88M | 798.63M | 798.54M | 765.36M | 763.41M | 773.10M | 762.01M | 720.00M | 751.51M | 733.05M | 749.35M |
| Goodwill | 133.00M | 133.00M | 155.59M | 155.59M | 155.59M | 155.59M | 155.59M | 155.59M | 155.59M | 155.59M | 155.59M | 155.59M |
| Long-Term Investments | — | — | — | — | — | — | — | — | 287.66M | 187.72M | 153.66M | 170.32M |
| Total Assets | 7.34B | 6.96B | 6.33B | 5.82B | 5.75B | 5.44B | 5.01B | 4.66B | 7.14B | 6.78B | 6.39B | 6.21B |
| Accounts Payable | 228.62M | 209.94M | 171.93M | 241.09M | 195.54M | 197.47M | 178.71M | 148.17M | 164.24M | 109.60M | 139.41M | 155.54M |
| Total Current Liabilities | 1.49B | 1.52B | 1.34B | 1.28B | 1.72B | 1.64B | 1.50B | 1.34B | 1.40B | 1.24B | 1.12B | 1.12B |
| Total Liabilities | 1.72B | 1.79B | 1.68B | 1.65B | 2.08B | 2.00B | 1.84B | 1.66B | 1.74B | 1.59B | 1.46B | 1.47B |
| Shareholders' Equity | 5.62B | 5.17B | 4.65B | 4.17B | 3.67B | 3.45B | 3.17B | 3.00B | 5.39B | 5.19B | 4.93B | 4.74B |
| Retained Earnings | 517.10M | 213.77M | -85.51M | -509.68M | -914.68M | -1.07B | -1.27B | -1.38B | 329.93M | 160.38M | -40.69M | -211.96M |
| Net Cash (Debt) | 3.46B | 3.10B | 2.46B | 1.95B | 1.94B | 1.69B | 1.77B | 1.45B | 3.85B | 3.66B | 3.52B | 3.42B |
| Shares Outstanding | 199.95M | 198.46M | 196.13M | 194.12M | 193.78M | 193.43M | 192.80M | 191.57M | 224.53M | 224.29M | 224.10M | 223.34M |
This table shows 12 quarterly periods of Incyte's balance sheet, from Q1 2026 back to Q2 2023, across 19 line items including cash & equivalents, short-term investments, inventory. Values in USD; B = billions, M = millions. Fiscal periods follow INCY's reporting calendar. What is a balance sheet?